Company intelligence / Profile preview

QualiMed Innovative Medizinprodukte

Winsen, Lower Saxony, Germany

Ownership: Private
Employees: ~54
Development stage: Other

Overview

QualiMed has obtained CE mark approval for over 70 different medical device products, including three drug-eluting stents with CE approval, and five unique biodegradable products for gastrointestinal indications. The company received CE mark approval for the UNITY-B Percutaneous Balloon Expandable Biodegradable Biliary Stent in June 2021.

Therapeutic areas: CardiovascularPulmonologyGastroenterology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on QualiMed Innovative Medizinprodukte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QualiMed Innovative Medizinprodukte.

Explore the full profile